On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...